Stocks with high levels of insider buying the past 3 months and good analyst coverage.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
388	HK$374.80	0.2%	-3.8%	HK$484.6b	HK$518.47	25.1	5.0%	3.5%	Diversified Financials
175	HK$18.59	-4.1%	17.4%	HK$205.3b	HK$29.24	11.3	16.8%	2.7%	Automobiles
2020	HK$71.05	-4.8%	-21.9%	HK$201.6b	HK$105.02	12.6	8.3%	3.4%	Consumer Durables
1929	HK$12.39	11.4%	-1.7%	HK$123.9b	HK$15.67	13.6	9.5%	5.4%	Retail
1177	HK$4.58	2.7%	-5.6%	HK$82.0b	HK$8.71	30.1	16.9%	2.2%	Pharmaceuticals & Biotech
6181	HK$458.40	3.4%	-43.9%	HK$79.9b	HK$936.42	14.4	19.3%	6.0%	Consumer Durables
1093	HK$6.89	-4.4%	-9.5%	HK$79.2b	HK$11.49	20.8	15.0%	4.2%	Pharmaceuticals & Biotech
9926 New	HK$87.55	-0.3%	-4.9%	HK$77.3b	HK$172.41	22.8	61.3%	n/a	Pharmaceuticals & Biotech
6862	HK$11.53	-6.3%	-20.2%	HK$65.2b	HK$17.72	13.7	9.5%	6.3%	Consumer Services
2313	HK$42.02	-2.3%	-19.6%	HK$64.1b	HK$65.83	9.4	7.3%	6.5%	Consumer Durables
960	HK$7.02	-17.9%	-24.4%	HK$53.4b	HK$10.30	42.1	33.8%	0%	Real Estate Management and Development
1364	HK$21.32	-3.9%	-5.9%	HK$50.5b	HK$34.32	14.1	14.5%	2.3%	Consumer Services
151	HK$4.05	-2.4%	-23.1%	HK$47.7b	HK$5.63	9.8	3.7%	3.9%	Food, Beverage & Tobacco
3939	HK$9.71	5.8%	23.3%	HK$46.1b	HK$16.66	27.4	46.6%	1.8%	Materials
1530 New	HK$16.23	-0.06%	-22.2%	HK$40.2b	HK$36.41	4.1	-38.7%	1.5%	Pharmaceuticals & Biotech
1828	HK$31.00	0.4%	n/a	HK$39.4b	HK$44.75	30.5	28.4%	n/a	Insurance
425	HK$29.52	-0.3%	52.0%	HK$36.6b	HK$49.39	11.1	13.2%	2.6%	Automobiles
23	HK$12.74	-3.0%	12.3%	HK$35.0b	HK$14.41	0.3	23.6%	4.8%	Banks
1877	HK$16.38	-0.7%	-23.5%	HK$30.2b	HK$29.91	5.3	69.1%	n/a	Pharmaceuticals & Biotech
1318	HK$56.50	-4.8%	-43.2%	HK$27.7b	HK$106.18	19.8	21.3%	2.1%	Household
1044	HK$23.22	-4.5%	7.5%	HK$27.6b	HK$29.18	9.1	3.3%	7.0%	Household
2096	HK$9.58	-1.3%	-5.3%	HK$24.2b	HK$17.87	15.8	18.0%	2.2%	Pharmaceuticals & Biotech
2245	HK$14.01	4.2%	37.4%	HK$23.2b	HK$28.34	6.6	3.5%	5.0%	Materials
290	HK$2.11	-30.1%	46.5%	HK$22.8b	n/a	101.0	n/a	n/a	Diversified Financials

High Insider Buying